60 related articles for article (PubMed ID: 10822372)
1. cRel-TD kinase: a serine/threonine kinase binding in vivo and in vitro c-Rel and phosphorylating its transactivation domain.
Fognani C; Rondi R; Romano A; Blasi F
Oncogene; 2000 Apr; 19(18):2224-32. PubMed ID: 10822372
[TBL] [Abstract][Full Text] [Related]
2. Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activity.
Starczynowski DT; Trautmann H; Pott C; Harder L; Arnold N; Africa JA; Leeman JR; Siebert R; Gilmore TD
Oncogene; 2007 Apr; 26(19):2685-94. PubMed ID: 17072339
[TBL] [Abstract][Full Text] [Related]
3. Mutations of tumor necrosis factor alpha-responsive serine residues within the C-terminal transactivation domain of human transcription factor REL enhance its in vitro transforming ability.
Starczynowski DT; Reynolds JG; Gilmore TD
Oncogene; 2005 Nov; 24(49):7355-68. PubMed ID: 16027730
[TBL] [Abstract][Full Text] [Related]
4. Divergent C-terminal transactivation domains of Rel/NF-kappa B proteins are critical determinants of their oncogenic potential in lymphocytes.
Fan Y; Rayet B; Gélinas C
Oncogene; 2004 Feb; 23(5):1030-42. PubMed ID: 14647412
[TBL] [Abstract][Full Text] [Related]
5. A chicken c-Rel-estrogen receptor chimeric protein shows conditional nuclear localization, DNA binding, transformation and transcriptional activation.
Zurovec M; Petrenko O; Roll R; Enrietto PJ
Oncogene; 1998 Jun; 16(24):3133-42. PubMed ID: 9671392
[TBL] [Abstract][Full Text] [Related]
6. Mutant envelope residues confer a transactivation function onto N-terminal sequences of the v-Rel oncoprotein.
Epinat JC; Kazandjian D; Harkness DD; Petros S; Dave J; White DW; Gilmore TD
Oncogene; 2000 Feb; 19(5):599-607. PubMed ID: 10698504
[TBL] [Abstract][Full Text] [Related]
7. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
[TBL] [Abstract][Full Text] [Related]
8. A mutant Rel-homology domain promotes transcription by p50/NFkappaB1.
Xu X; Gélinas C
Oncogene; 1997 Apr; 14(13):1521-30. PubMed ID: 9129142
[TBL] [Abstract][Full Text] [Related]
9. Regulation and function of IKK and IKK-related kinases.
Häcker H; Karin M
Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
[TBL] [Abstract][Full Text] [Related]
10. Nuclear accumulation of cRel following C-terminal phosphorylation by TBK1/IKK epsilon.
Harris J; Olière S; Sharma S; Sun Q; Lin R; Hiscott J; Grandvaux N
J Immunol; 2006 Aug; 177(4):2527-35. PubMed ID: 16888014
[TBL] [Abstract][Full Text] [Related]
11. Ser484 and Ser494 in REL are the major sites of IKK phosphorylation in vitro: evidence that IKK does not directly enhance GAL4-REL transactivation.
Garbati MR; Gilmore TD
Gene Expr; 2008; 14(4):195-205. PubMed ID: 19110719
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of IkappaBalpha in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability.
Lin R; Beauparlant P; Makris C; Meloche S; Hiscott J
Mol Cell Biol; 1996 Apr; 16(4):1401-9. PubMed ID: 8657113
[TBL] [Abstract][Full Text] [Related]
13. NF-kappaB-inducing kinase is involved in the activation of the CD28 responsive element through phosphorylation of c-Rel and regulation of its transactivating activity.
Sánchez-Valdepeñas C; Martín AG; Ramakrishnan P; Wallach D; Fresno M
J Immunol; 2006 Apr; 176(8):4666-74. PubMed ID: 16585559
[TBL] [Abstract][Full Text] [Related]
14. Regulation of nuclear factor kappa B transactivation. Implication of phosphatidylinositol 3-kinase and protein kinase C zeta in c-Rel activation by tumor necrosis factor alpha.
Martin AG; San-Antonio B; Fresno M
J Biol Chem; 2001 May; 276(19):15840-9. PubMed ID: 11278885
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of c-Rel transcriptional activity by PKA catalytic subunit beta.
Yu SH; Chiang WC; Shih HM; Wu KJ
J Mol Med (Berl); 2004 Sep; 82(9):621-8. PubMed ID: 15197457
[TBL] [Abstract][Full Text] [Related]
16. Regulation of constitutive p50/c-Rel activity via proteasome inhibitor-resistant IkappaBalpha degradation in B cells.
O'Connor S; Shumway SD; Amanna IJ; Hayes CE; Miyamoto S
Mol Cell Biol; 2004 Jun; 24(11):4895-908. PubMed ID: 15143182
[TBL] [Abstract][Full Text] [Related]
17. Activation of the transcriptional function of the NF-κB protein c-Rel by O-GlcNAc glycosylation.
Ramakrishnan P; Clark PM; Mason DE; Peters EC; Hsieh-Wilson LC; Baltimore D
Sci Signal; 2013 Aug; 6(290):ra75. PubMed ID: 23982206
[TBL] [Abstract][Full Text] [Related]
18. Methods for assessing the in vitro transforming activity of NF-κB transcription factor c-Rel and related proteins.
Gilmore TD; Gélinas C
Methods Mol Biol; 2015; 1280():427-46. PubMed ID: 25736765
[TBL] [Abstract][Full Text] [Related]
19. Constitutive phosphorylation of I kappa B alpha by casein kinase II.
Barroga CF; Stevenson JK; Schwarz EM; Verma IM
Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7637-41. PubMed ID: 7644469
[TBL] [Abstract][Full Text] [Related]
20. Deletion of either C-terminal transactivation subdomain enhances the in vitro transforming activity of human transcription factor REL in chicken spleen cells.
Starczynowski DT; Reynolds JG; Gilmore TD
Oncogene; 2003 Oct; 22(44):6928-36. PubMed ID: 14534540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
